The shares were sold at a weighted average price, with prices ranging from $28.59 to $28.63 per share, amounting to a total ...
Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company ...
On track to complete enrollment in del-desiran HARBOR TM Phase 3 and potential registrational del-brax biomarker cohort as well as initiate global pivotal trial for del-brax by mid-2025 Eric ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results